Tag Archives: Cardiology

Heart disease remains the leading cause of illness and death among people with diabetes. However, one of the most concerning complications, diabetic cardiomyopathy, often develops quietly for years before symptoms emerge. During this silent phase, routine echocardiograms frequently show a normal ejection fraction, creating a false sense of reassurance. Fortunately, …

The treatment landscape for type 2 diabetes has changed dramatically over the past decade. While selective SGLT2 inhibitors have become a cornerstone of diabetes management because of their proven cardiovascular and kidney benefits, researchers are now exploring the added potential of dual SGLT1/2 inhibitor therapy for people with diabetes. By …

For many people living with type 2 diabetes, the biggest challenge is not finding an effective medication. It is being able to afford it. That reality may begin to change now that the U.S. Food and Drug Administration (FDA) has approved the first generic versions of Farxiga (dapagliflozin), potentially making …

Not long ago, diabetes management focused primarily on controlling blood glucose levels. Today, that approach has evolved dramatically as cardiologists and endocrinologists increasingly work together to reduce cardiovascular risk. Thanks to groundbreaking cardiovascular outcome trials (CVOTs), clinicians now understand that treating type 2 diabetes means protecting the heart, kidneys, and …

Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …

Diabetes is a serious disease that affects millions of people worldwide. It is associated with an increased risk of cardiovascular disease and other complications. To reduce this risk, various lipid-lowering agents have been developed to lower cholesterol levels and reduce the risk of cardiovascular disease. This article reviews the current …

Estimated costs comparable to 1.8 percent of GDP across eight countries in 2019; economic impact projected to increase to 3.6 percent by 2060

Insulin pump use higher among White versus Black and other Medicare beneficiaries

High-quality evidence shows association between alternate-day fasting and moderate reduction in BMI for healthy adults and those with overweight, obesity

Most cardiovascular conditions more strongly linked to cognition among women